Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.

Pfeiffer, Steffen

Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. [electronic resource] - Transplantation Apr 2003 - 953-9 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0041-1337

10.1097/01.TP.0000058517.07194.90 doi


Acute Disease
Animals
Aurintricarboxylic Acid--pharmacology
Blood Physiological Phenomena
Blood Platelets--drug effects
Complement Activation--drug effects
Dipeptides--pharmacology
Drug Synergism
Graft Rejection--metabolism
Graft Survival
Hematocrit
Histamine--blood
Humans
Lung--drug effects
Lung Transplantation
Platelet Glycoprotein GPIIb-IIIa Complex--metabolism
Platelet Glycoprotein GPIb-IX Complex--metabolism
Platelet Membrane Glycoproteins
Swine
Thrombin--biosynthesis
Thromboxane B2--metabolism
Transplantation, Heterologous